GIA
TARS icon

GHP Investment Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

GHP Investment Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63 Hold
1
– – ﹤0.01% 1325
2026
Q1 		$71 Buy
+1
New +$70 ﹤0.01% 1343

Other funds holding TARS

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

GHP Investment Advisors's TARS Position: Q2 2026 in Review

GHP Investment Advisors held its Tarsus Pharmaceuticals (TARS) position steady in Q2 2026 at 1 share worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

GHP Investment Advisors first reported a position in TARS in Q1 2026 and has held it in 2 quarters since. The position peaked at $71 in Q1 2026. 39 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • GHP Investment Advisors held 1 share of Tarsus Pharmaceuticals worth $63 as of Q2 2026.
  • GHP Investment Advisors left its Tarsus Pharmaceuticals share count unchanged in Q2 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1325 holding.
  • GHP Investment Advisors first reported a position in Tarsus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • GHP Investment Advisors's Tarsus Pharmaceuticals position peaked at $71 in Q1 2026.
  • 39 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.